Clinical Trial Update: Clinical Trial Investigating Pazopanib in Patients With Platinum-resistant Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pazopanib for platinum-resistant advanced ovarian cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Votrient (Pazopanib)

Snippet

Sponsor: Grupo Español de Investigación en Cáncer de Ovario | Conditions: Platinum-resistant Advanced Ovarian Cancer | Phase 2 | Status: COMPLETED